HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, eleven have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $113.53.
Several research firms recently issued reports on HQY. Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a research note on Friday, August 28th. Weiss Ratings cut shares of HealthEquity from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday. BMO Capital Markets increased their target price on shares of HealthEquity from $105.00 to $125.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Friday, August 28th. Finally, Deutsche Bank raised their target price on HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a report on Monday, August 31st.
Insider Activity
In other news, Director Adrian Dillon sold 7,632 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the transaction, the director owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. This represents a 10.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.60% of the company’s stock.
Institutional Investors Weigh In On HealthEquity
Several institutional investors and hedge funds have recently added to or reduced their stakes in HQY. BlackRock Inc. bought a new position in shares of HealthEquity during the 2nd quarter worth about $1,018,621,000. William Blair Investment Management LLC bought a new stake in shares of HealthEquity in the second quarter valued at about $160,158,000. Bank of America Corp DE bought a new stake in shares of HealthEquity in the second quarter valued at about $103,573,000. Atalan Capital Partners LP bought a new stake in shares of HealthEquity in the second quarter valued at about $82,667,000. Finally, Jupiter Topco LLC bought a new stake in shares of HealthEquity in the second quarter valued at about $78,847,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.
HealthEquity Price Performance
Shares of HQY opened at $101.84 on Wednesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99. The firm has a market cap of $8.42 billion, a PE ratio of 36.77, a PEG ratio of 1.65 and a beta of 0.22. The firm’s 50 day moving average price is $96.42 and its 200 day moving average price is $90.17. HealthEquity has a twelve month low of $72.76 and a twelve month high of $110.26.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. The firm’s quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, research analysts expect that HealthEquity will post 3.94 EPS for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.
See Also
- Five stocks we like better than HealthEquity
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
